GlassScriptPhysician profile
Ryan Curtis Simmons
NPI 1548271448
$1,592.47
in general payments reported to CMS, 2019-2025
18 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $111 · 2021: $59.15 · 2022: $287 · 2023: $120 · 2024: $316 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $438.74 | 2020-2025 | |
| Intersect Ent, INC. | $213.47 | 2019-2021 | |
| Aerin Medical INC. | $175.12 | 2021-2025 | |
| Cumberland Pharmaceuticals, INC. | $143.65 | 2019-2022 | |
| Inspire Medical Systems, INC. | $137.78 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $102.53 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $70.58 | 2024-2025 | Nucala |
| Acclarent, INC | $59.89 | 2019-2023 | Trudi Nav Cable |
| Stryker Corporation | $51.44 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $48.38 | 2024-2025 | Voquezna |
| Olympus America INC. | $30.29 | 2020-2022 | |
| Neurent Medical Limited | $22.54 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Coopersurgical, INC. | $19.87 | 2025 | Onetrac Lx |
| Medtronic, INC. | $17.67 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $17.26 | 2025 | Neffy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.19 | 2023 | |
| Arbor Pharmaceuticals, INC. | $14.63 | 2019 | |
| Boston Scientific Corporation | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.